Syntopix signs deal with healthcare marketing company

Syntopix, a developer of topical antimicrobial solutions for the medicinal and consumer healthcare markets, has signed an exclusive agreement with a marketing company focused on home, health and personal-care brands.

Under the terms of the agreement, Syntopix has granted the rights of first refusal to the company to negotiate a separate agreement for the further development and eventual commercialisation of a compound that is currently under clinical evaluation.

Syntopix will receive payments throughout the clinical phase.